CpG motifs as immune adjuvants

By Klinman D.M.   Barnhart K.M.   Conover J.  

Vaccine, Vol. 17, Iss. 1, 1999-01 ,pp. : 19-25

Elsevier

Access to resources Recommend Favorite

Poly-l-arginine synergizes with oligodeoxynucleotides containing CpG-motifs (CpG-ODN) for enhanced and prolonged immune responses and prevents the CpG-ODN-induced systemic release of pro-inflammatory cytokines

By Lingnau K.   Egyed A.   Schellack C.   Mattner F.   Buschle M.   Schmidt W.  

Vaccine, Vol. 20, Iss. 29, 2002-10 ,pp. : 3498-3508

Elsevier

Access to resources Recommend Favorite

Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys

By Jones T.R.   Obaldia N.   Gramzinski R.A.   Charoenvit Y.   Kolodny N.   Kitov S.   Davis H.L.   Krieg A.M.   Hoffman S.L.  

Vaccine, Vol. 17, Iss. 23, 1999-08 ,pp. : 3065-3071

Elsevier

Access to resources Recommend Favorite

CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus

By Moldoveanu Z.   Love-Homan L.   Huang W.Q.   Krieg A.M.  

Vaccine, Vol. 16, Iss. 11, 1998-07 ,pp. : 1216-1224

Elsevier

Access to resources Recommend Favorite

Enhanced immune response to T-independent antigen by using CpG oligodeoxynucleotides encapsulated in liposomes

By Li W.M.   Bally M.B.   Schutze-Redelmeier M.-P.  

Vaccine, Vol. 20, Iss. 1, 2001-10 ,pp. : 148-157

Elsevier

Access to resources Recommend Favorite